Erratum: Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells (PLoS ONE (2014) 9:1 (e87371) DOI: 10.1371/journal.pone.0087371);Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mahalingaiah, Prathap Kumar S ^a   Singh, Kamaleshwar P ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; HERMES ANTIGEN; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SURVIVIN; UVOMORULIN; VASCULOTROPIN; WNT1 PROTEIN;

ARTICLE; BCL 2 GENE; CANCER GROWTH; CARCINOGENICITY; CD44 GENE; CDH1 GENE; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; CYCLIND1 GENE; GENE EXPRESSION; LONG TERM EXPOSURE; MCF 7 CELL LINE; OXIDATIVE STRESS; POLY(ADP RIBOSE)POLYMERASE 1 GENE; SURVIVIN GENE; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; WNT1 GENE;

CELL COUNT; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; HYDROGEN PEROXIDE; MCF-7 CELLS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84898663754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093799     Document Type: Erratum

References (71)

1. Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, et al. (2007) Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer 109: 2627-2634. (Pubitemid 46906451)
2. Lan T, Wang L, Xu Q, Liu W, Jin H, et al. (2013) Growth inhibitory effect of Cucurbitacin E on breast cancer cells. Int J Clin Exp Pathol 6: 1799-1805.
3. Owens TW, Naylor MJ (2013) Breast cancer stem cells. Front Physiol 4: 225.
4. Florea AM, Busselberg D (2011) Metals and breast cancer: risk factors or healing agents? J Toxicol 2011: 159619.
5. Travis RC, Reeves GK, Green J, Bull D, Tipper SJ, et al. (2010) Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet 375: 2143-2151.
6. Nickels S, Truong T, Hein R, Stevens K, Buck K, et al. (2013) Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 9: e1003284.
7. Rathore K, Choudhary S, Odoi A, Wang HC (2012) Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis 33: 174-183.
8. Fenton SE, Reed C, Newbold RR (2012) Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood. Annu Rev Pharmacol Toxicol 52: 455-479.
9. Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz GS, et al. (2001) 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 93: 768-776. (Pubitemid 32514800)
10. St-Hilaire S, Mandal R, Commendador A, Mannel S, Derryberry D (2011) Estrogen receptor positive breast cancers and their association with environmental factors. Int J Health Geogr 10: 32.
11. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, et al. (2000) Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr: 95-112.
12. Zhai Y, Santucci-Pereira J, de Cicco RL, Russo IH, Russo J (2012) An - model of epithelial mesenchymal transition in triple negative breast cancer. Drug Discov Today Dis Mech 9: e35-e40.
13. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282.
14. Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ (2013) Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids 78: 161-170.
15. Roy D, Singh KP (2004) Estrogen-Induced genetic alterations and their role in carcinogenicity. Current Genomics 5: 245-257. (Pubitemid 38477351)
16. Lerebours F, Lidereau R (2002) Molecular alterations in sporadic breast cancer. Crit Rev Oncol Hematol 44: 121-141. (Pubitemid 36159042)
17. Niederacher D, An HX, Cho YJ, Hantschmann P, Bender HG, et al. (1999) Mutations and amplification of oncogenes in endometrial cancer. Oncology 56: 59-65. (Pubitemid 29043898)
18. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr: 75-93.
19. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947. (Pubitemid 27148818)
20. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63-78. (Pubitemid 44175632)
21. Patel MM, Bhat HK (2004) Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: Involvement of metabolic activation and cytochrome P450. J Biochem Mol Toxicol 18: 37-42. (Pubitemid 38312721)
22. Cavalieri EL, Rogan EG (2004) A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci 1028: 247-257. (Pubitemid 40361826)
23. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci U S A 100: 3913-3918. (Pubitemid 36418131)
24. Mense SM, Remotti F, Bhan A, Singh B, El-Tamer M, et al. (2008) Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol 232: 78-85.
25. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, et al. (2000) Increased formation of oxidative DNA damage, 8-hydroxy-29-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 151: 87-95. (Pubitemid 30155589)
26. Brown NS, Bicknell R (2001) Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3: 323-327. (Pubitemid 32851163)
27. Zhao M, Wi H, Oh TI, Woo EJ (2013) Evaluation of anomaly detection algorithm using trans-admittance mammography with 60x60 electrode array. Conf Proc IEEE Eng Med Biol Soc 2013: 6433-6436.
28. Kundu N, Zhang S, Fulton AM (1995) Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma. Clin Exp Metastasis 13: 16-22.
29. Paul S, Sengupta S, Bandyopadhyay TK, Bhattacharyya A (2012) Stevioside induced ROS-mediated apoptosis through mitochondrial pathway in human breast cancer cell line MCF-7. Nutr Cancer 64: 1087-1094.
30. Santner SJ, Pauley RJ, Tait L, Kaseta J, Santen RJ (1997) Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 82: 200-208. (Pubitemid 27021297)
31. Ferlini C, Scambia G, Marone M, Distefano M, Gaggini C, et al. (1999) Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br J Cancer 79: 257-263. (Pubitemid 29002294)
32. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7: 97-110. (Pubitemid 38736063)
33. Deng YT, Huang HC, Lin JK (2010) Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog 49: 141-151.
34. Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SM, et al. (2013) Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacol Rep 65: 700-709.
35. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
36. Hwang SL, Yen GC (2008) Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J Agric Food Chem 56: 859-864.
37. Saud A (2011) Assessemnt of MCF-7 cells as an invitro model system for evaluation of chemical oxidative stressors. African Journal of Biotechnology 10:3872-3879.
38. Ganie SA, Haq E, Hamid A, Masood A, Zargar MA (2011) Long dose exposure of hydrogen peroxide (H2O2) in albino rats and effect of Podophyllum hexandrum on oxidative stress. Eur Rev Med Pharmacol Sci 15: 906-915.
39. Waghray M, Cui Z, Horowitz JC, Subramanian IM, Martinez FJ, et al. (2005) Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. Faseb j 19: 854-856. (Pubitemid 40617407)
40. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40. (Pubitemid 43227479)
41. Storz P, Doppler H, Toker A (2005) Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol Cell Biol 25: 8520-8530. (Pubitemid 41369173)
42. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA (2000) Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28: 1456-1462. (Pubitemid 30604227)
43. Okoh VO, Felty Q, Parkash J, Poppiti R, Roy D (2013) Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One 8: e54206.
44. Fujita T, Maruyama M, Araya J, Sassa K, Kawagishi Y, et al. (2002) Hydrogen peroxide induces upregulation of Fas in human airway epithelial cells via the activation of PARP-p53 pathway. Am J Respir Cell Mol Biol 27: 542-552. (Pubitemid 35301808)
45. Geiser T, Ishigaki M, van Leer C, Matthay MA, Broaddus VC (2004) H(2)O(2) inhibits alveolar epithelial wound repair in vitro by induction of apoptosis. Am J Physiol Lung Cell Mol Physiol 287: L448-453. (Pubitemid 38943928)
46. Heirman I, Ginneberge D, Brigelius-Flohe R, Hendrickx N, Agostinis P, et al. (2006) Blocking tumor cell eicosanoid synthesis by GP x 4 impedes tumor growth and malignancy. Free Radic Biol Med 40: 285-294. (Pubitemid 43069352)
47. Okada F, Shionoya H, Kobayashi M, Kobayashi T, Tazawa H, et al. (2006) Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase. Br J Cancer 94: 854-862.
48. Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37-52. (Pubitemid 351753035)
49. Nishikawa M, Hyoudou K, Kobayashi Y, Umeyama Y, Takakura Y, et al. (2005) Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J Control Release 109: 101-107. (Pubitemid 41737256)
50. Imanishi H, Hattori K, Wada R, Ishikawa K, Fukuda S, et al. (2011) Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PLoS One 6: e23401.
51. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI (2008) Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 266: 6-11.
52. Goitre L, Pergolizzi B, Ferro E, Trabalzini L, Retta SF (2012) Molecular Crosstalk between Integrins and Cadherins: Do Reactive Oxygen Species Set the Talk? J Signal Transduct 2012: 807682.
53. Saha Roy S, Vadlamudi RK (2012) Role of estrogen receptor signaling in breast cancer metastasis. Int J Breast Cancer 2012: 654698.
54. Beavon IR (2000) The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 36: 1607-1620.
55. Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, et al. (2003) Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res 63: 5203-5208. (Pubitemid 37139828)
56. Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13: 11-26.
57. Mori K, Shibanuma M, Nose K (2004) Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 64: 7464-7472. (Pubitemid 39372089)
58. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284. (Pubitemid 46706514)
59. Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66: 1883-1890; discussion 1895-1886.
60. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988. (Pubitemid 36418143)
61. Owens TW, Naylor MJ (2013) Breast cancer stem cells. Frontiers in Physiology 4.
62. Azad N, Rojanasakul Y, Vallyathan V (2008) Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 11: 1-15.
63. Liu L, Yang Z, Xu Y, Li J, Xu D, et al. (2013) Inhibition of oxidative stress-elicited AKT activation facilitates PPARgamma agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. PLoS One 8: e73038.
64. Ao A, Morrison BJ, Wang H, Lopez JA, Reynolds BA, et al. (2011) Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. PLoS One 6: e18810.
65. Lin CH, Hung PH, Chen YJ (2013) CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation. Int J Mol Sci 14: 13266-13281.
66. Sullivan R, Graham CH (2008) Chemosensitization of cancer by nitric oxide. Curr Pharm Des 14: 1113-1123. (Pubitemid 351982558)
67. Pervaiz S, Clement MV (2004) Tumor intracellular redox status and drug resistance-serendipity or a causal relationship? Curr Pharm Des 10: 1969-1977. (Pubitemid 38647581)
68. Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, et al. (2005) Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 65: 8455-8460. (Pubitemid 41330613)
69. Hoshida Y, Moriyama M, Otsuka M, Kato N, Taniguchi H, et al. (2007) Gene expressions associated with chemosensitivity in human hepatoma cells. Hepatogastroenterology 54: 489-492. (Pubitemid 46724713)
70. Achuthan S, Santhoshkumar TR, Prabhakar J, Nair SA, Pillai MR (2011) Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species. J Biol Chem 286: 37813-37829.
71. Alexandre J, Hu Y, Lu W, Pelicano H, Huang P (2007) Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 67: 3512-3517. (Pubitemid 46762129)